Reference Citation Analysis: Find an Article, Find a Category, Find a Journal, Find a Scholar

For: Mamdani H, Jalal SI. Breakthroughs and challenges in the management of tropomyosin receptor kinase fusion-positive tumors. Ann Transl Med 2019;7:S155. [PMID: 31576362 DOI: 10.21037/atm.2019.06.41] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/06/2022]

For:	Mamdani H, Jalal SI. Breakthroughs and challenges in the management of tropomyosin receptor kinase fusion-positive tumors. Ann Transl Med 2019;7:S155. [PMID: 31576362 DOI: 10.21037/atm.2019.06.41] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/06/2022]

Number

Cited by Other Article(s)

Kargbo RB. PROTAC Compounds Targeting TRK for Use in Cancer Therapeutics. ACS Med Chem Lett 2020;11:1090-1091. [PMID: 32550985 DOI: 10.1021/acsmedchemlett.0c00235] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/02/2020] [Indexed: 11/27/2022] Open